Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Flucloxacillin].

S Mastroviti, G Cassarino

    Giornale Di Batteriologia, Virologia Ed Immunologia
    |July 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Flucloxacillin, a novel penicillin antibiotic, demonstrates superior absorption and lower toxicity compared to similar drugs. It is highly effective against Gram-positive bacteria, including staphylococci, and successful in treating respiratory and soft tissue infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Is therapy of temporomandibular dysfunction an orthodontic problem? II].

    Minerva stomatologica·1989
    Same author

    [Is the treatment of temporo-mandibular dysfunction an orthodontic problem? I].

    Minerva stomatologica·1989
    Same author

    [Bone inclusion and ectopia of a superior incisor. Clinical case].

    Minerva stomatologica·1989
    Same author

    [Response of facial soft tissues following interventions of mandibular regression. Frontal examination].

    Minerva stomatologica·1989
    Same author

    [Comparative analysis of clinical indications and cephalometry in orthognathic surgery. II].

    Minerva stomatologica·1988
    Same author

    [Comparative analysis of clinical indications and cephalometric data in orthognathic surgery. I].

    Minerva stomatologica·1988
    Same journal

    [Prevalence of urinary infections caused by GBS in diabetic patients].

    Giornale di batteriologia, virologia ed immunologia·1994
    Same journal

    [Epidemiologic study of infectious diarrhea in infants].

    Giornale di batteriologia, virologia ed immunologia·1994
    Same journal

    [The role of cytokines in viral infections].

    Giornale di batteriologia, virologia ed immunologia·1994
    Same journal

    [Serum stimulates the transcriptional activity of the enhancer of the immediate-early genes of the murine cytomegalovirus through p21 ras].

    Giornale di batteriologia, virologia ed immunologia·1994
    Same journal

    [Protein p53 inhibits the activity of the enhancer of the immediate-early genes of murine cytomegalovirus].

    Giornale di batteriologia, virologia ed immunologia·1994
    Same journal

    Viral evasion of cytokine-mediated host defense mechanisms.

    Giornale di batteriologia, virologia ed immunologia·1994
    See all related articles

    Area of Science:

    • Pharmacology and Clinical Medicine
    • Antimicrobial Agents

    Background:

    • Introduction of flucloxacillin as a new isoxazolilpenicillin.
    • Comparison of flucloxacillin's properties with existing antibiotics like cloxacillin, oxacillin, and dicloxacillin.

    Purpose of the Study:

    • To report the pharmacological and clinical properties of flucloxacillin.
    • To evaluate its efficacy and safety in treating bacterial infections.

    Main Methods:

    • Pharmacological property assessment (toxicity, absorption, protein binding).
    • In vitro evaluation of antibacterial activity against various bacteria, especially staphylococci.
    • Clinical case studies of flucloxacillin treatment for infections.

    Main Results:

    Related Experiment Videos

  • Flucloxacillin exhibits low acute and chronic toxicity.
  • Demonstrates higher enteric absorption than cloxacillin and oxacillin.
  • Shows lower serum protein binding than dicloxacillin.
  • Potent activity against Gram-positive bacteria, particularly penicillinase-producing staphylococci.
  • Successful clinical outcomes in treating respiratory apparatus and soft tissue infections.

    • Conclusions:

    • Flucloxacillin is a promising antibiotic with favorable pharmacokinetic and safety profiles.
    • Its efficacy against resistant staphylococci and common infections makes it a valuable therapeutic option.